Two patients with acute thrombocytopenia following gold administration and five-year follow-up

Netherlands Journal of Medicine

Volumn 61, Issue 6, 2003, Pages 223-225

  Levin, M D ^a   van't Veer, M B ^a   de Veld, J C ^a   Markusse, H M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Medisch Centrum Rijnmond Zuid   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOGLUCOSE; CALCIUM; GOLD DERIVATIVE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INDOMETACIN; PREDNISONE; SALAZOSULFAPYRIDINE; THROMBOCYTE ANTIBODY; VITAMIN D; ANTIRHEUMATIC AGENT;

ACUTE DISEASE; ADULT; ANTIBODY DETECTION; ARTICLE; BLEEDING TENDENCY; BONE MARROW BIOPSY; CASE REPORT; CELL DESTRUCTION; CONVALESCENCE; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; MEGAKARYOPOIESIS; PETECHIA; RHEUMATOID ARTHRITIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; TIME;

ACUTE DISEASE; ANTIRHEUMATIC AGENTS; AUROTHIOGLUCOSE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; THROMBOCYTOPENIA; TIME FACTORS;

EID: 0141462640     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998;129:886-90.
2. Harth M, Hickey PJ, Coulter KW, Thompson JM, Disney TF. Gold-induced thrombocytopenia. J Rheumatol 1978;5:165-72.
3. Coblyn JS, Weinblatt M, Holdsworth D, Glass D. Gold-induced thrombocytopenia. Ann Int Med 1981;95:178-81.
4. Williame LME, Joos R, Proot F, Immesoete C. Gold-induced aplastic anemia. Clin Rheumatol 187;6:600-5.
5. Yan A, Davis PJ. Gold induced marrow suppression: a review of 10 cases. Rheumatol 1990;17:47-51.
6. Armstrong RD, Faith A, Panayi GS, Batchelor JR. Gold-induced thrombocytopenia: detection of anti-platelet antibody. Clin Rheumatol 1983;2:183-8.
7. Levin HA, McMillan R, Tavassoli M, Longmire RL, Yelenosky R, Sacks PV. Thrombocytopenia associated with gold therapy. Observations on the mechanism of platelet destruction. Am J Med 1975;59:274-80.
8. Sintnicolaas K, Vries W de, Linden R van der, Gratama JW, Bolhuis RLH. Simultaneous flow cytometric detection of antibodies against platelets, granulocytes and lymfocytes. J Immun Meth 1991;142:215-22.
9. Gratama JW, Linden R van der, Vries W de, et al. Simultaneous detection of IgM and IgG antibodies against platelets, lymphocytes, and granulocytes by flow cytometry. Infus Ther Transfus Med 1998;25:317-24.
10. Jessop JD, Johns RGS. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate. Ann Rheum Dis 1972;32:228-32.
11. Gerber RC, Paulus HE, Bleustone R, Lederer M. Kinetics of Aurothiomalate in serum and synovial fluid. Arthritis Rheum 1972;15:625-9.
12. Gottlieb NL, Smith PM, Smith EM. Pharmacodynamics of 197Au and 195Au labeled Aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion. Arthritis Rheum 1974;17:171-83.
13. Rubinstein HR, Dietz AA. Serum gold. II Levels in rheumatoid arthritis. 1973;32:128-32.
14. Krusius F-E, Markkanen A, Peltola P. Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis. Ann Rheum Dis1970;29:232-5.
15. Mascarenhas BR, Granda JL, Freyberg RH. Gold metabolism in patients with rheumatoid arthritis treatment with gold compounds reinvestigated. Arthritis Rheum 1972;15:391-402.
16. Bensen WG, Moore N, Tugwell P, D'Souza M, Singal DP. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis. J Rheumatol 1984;11:358-61.
17. Adachi JD, Bensen WG, Singal DP, Powers PJ. Gold induced thrombocytopenia: platelet associated IgG and HLA typing in three patients. J Rheumatol 1984;11:355-7.